Nobutaka Ikeda
Nobutaka Ikeda publishes mostly in Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Pulmonary Hypertension Research and Treatments.
- World rank
- #1,378,084 of 7,710,434 ranked researchers
- Rank in Japan
- #21,211 of 383,136
- Works
- 214
- Citations
- 2.2k
- Citations per work
- 10.3
What does Nobutaka Ikeda research?
Nobutaka Ikeda's work is mostly in Medicine (77%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences16576.9%
- Medicine16576.9%
- Everything else4923.1%
- 1Cardiology and Cardiovascular Medicine28% of their works
- 2Pulmonary and Respiratory Medicine16% of their works
- 3Internal Medicine15% of their works
- 4Surgery10% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Infectious Diseases4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Pulmonary Hypertension Research and Treatments
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Health and Disease Prevention
- Cardiac Imaging and Diagnostics
- COVID-19 Clinical Research Studies
- Coronary Interventions and Diagnostics
Which keywords describe Nobutaka Ikeda's research?
The keywords of their largest research topics: Antithrombotic Therapy, Venous Thromboembolism, Stroke Prevention, Endothelial Dysfunction, Anticoagulant Therapy, Atrial Fibrillation, Magnetic Resonance Imaging and Pulmonary Hypertension.
- Coronary Stents
- Clinical Characteristics
- Cardiac Imaging
- Arterial Stiffness
- Carotid Artery Stenosis
- Pulmonary Hypertension
- Atrial Fibrillation
- Endothelial Dysfunction
- Venous Thromboembolism
- Antithrombotic Therapy
- Stroke Prevention
- Anticoagulant Therapy
- Magnetic Resonance Imaging
- Right Heart Assessment
- Endarterectomy
- Cardiovascular Events
- Coronary Artery Disease
- SARS-CoV-2
- Myocardial Revascularization
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Antithrombotic Therapy841 topic
- Venous Thromboembolism841 topic
- Stroke Prevention752 topics
- Endothelial Dysfunction712 topics
- Anticoagulant Therapy481 topic
- Atrial Fibrillation481 topic
- Magnetic Resonance Imaging482 topics
- Pulmonary Hypertension461 topic
- Right Heart Assessment461 topic
- Carotid Artery Stenosis271 topic
- Endarterectomy271 topic
- Arterial Stiffness251 topic
- Cardiovascular Events251 topic
- Cardiac Imaging211 topic
- Coronary Artery Disease211 topic
- Clinical Characteristics191 topic
- SARS-CoV-2191 topic
- Coronary Stents171 topic
- Myocardial Revascularization171 topic
Where does Nobutaka Ikeda work?
Nobutaka Ikeda's main affiliation in the publication record is Toho University, Japan.
How many publications and citations does Nobutaka Ikeda have?
OpenAlex counts 214 works and 2,210 citations for Nobutaka Ikeda, an h-index of 27, ranking #1,378,084 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nobutaka Ikeda. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.